Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis

Human Genetics

Volumn 131, Issue 3, 2012, Pages 513-523

  Armengol, Lluís ^a   Nevado, Julián ^b,c   Serra Juhé, Clara ^c,d   Plaja, Alberto ^e   Mediano, Carmen ^e   García Santiago, Fe Amalia ^b,c   García Aragonés, Manel ^a   Villa, Olaya ^c,d   Mansilla, Elena ^b,c   Preciado, Cristina ^c,d   Fernández, Luis ^b,c   Mori, María Ángeles ^b,c   García Pérez, Lidia ^f,g   Lapunzina, Pablo Daniel ^b,c   Pérez Jurado, Luis Alberto ^c,d,e  

^a QGenomics Laboratory   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f Fundacion Canaria de Investigacion y Salud FUNCIS   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHROMOSOMAL MICROARRAY ANALYSIS; CHROMOSOME ABERRATION; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FETUS; FETUS MONITORING; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INFORMED CONSENT; INHERITANCE; INTERMETHOD COMPARISON; INVASIVE PROCEDURE; KARYOTYPING; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MULTICENTER STUDY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUANTITATIVE FLUORESCENT POLYMERASE CHAIN REACTION; SAMPLING; TREATMENT INDICATION; CHROMOSOME DISORDER; CLINICAL TRIAL; DNA MICROARRAY; ECONOMICS; GENETICS; KARYOTYPE; METHODOLOGY; PREGNANCY; SENSITIVITY AND SPECIFICITY;

ADULT; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; HUMANS; KARYOTYPE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84859494373     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-011-1095-5     Document Type: Article

References (29)

1. Altman DG, Machin D, Bryant TN, Gardner MJ (eds) (2000) Statistics with confidence, 2nd edn. British Medical Journal Books, London, pp 28-29
2. Benacerraf BR, Gelman R, Frigoletto FD Jr (1987) Sonographic identification of second-trimester fetuses with Down's syndrome. N Engl J Med 317(22):1371-1376
3. Berg JS, Potocki L, Bacino CA (2010) Common recurrent microduplication syndromes: diagnosis and management in clinical practice. Am J Med Genet A 152A(5):1066-1078
4. Blennow E, Bui TH, Kristoffersson U, Vujic M, Anneren G, Holmberg E, Nordenskjold M (1994) Swedish survey on extra structurally abnormal chromosomes in 39 105 consecutive prenatal diagnoses: prevalence and characterization by fluorescence in situ hybridization. Prenat Diagn 14(11):1019-1028
5. Carlson JJ, Henrikson NB, Veenstra DL, Ramsey SD (2005) Economic analyses of human genetics services: a systematic review. Genet Med 7(8):519-523 00125817-200510000-00001[pii]
6. Caspersson T, Zech L, Johansson C, Modest EJ (1970) Identification of human chromosomes by DNA-binding fluorescent agents. Chromosoma 30(2):215-227
7. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM,Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ (Clin Res ed) 342:c7401. doi:10.1136/bmj.c7401
8. Collet D (1999) Modelling binary data. Chapman & Hall/CRC, Boca Ratón
9. Coppinger J, Alliman S, Lamb AN, Torchia BS, Bejjani BA, Shaffer LG (2009) Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarray. Prenat Diagn 29(12):1156-1166. doi:10.1002/pd.2371
10. Cuckle HS, Wald NJ, Thompson SG (1987) Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94(5):387-402
11. Driscoll DA, Gross S (2009) Clinical practice. Prenatal screening for aneuploidy. N Engl J Med 360(24):2556-2562
12. Drummond MF, Sculpher MJ, Torrance GW (2005) Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford
13. Flint J, Wilkie AO, Buckle VJ, Winter RM, Holland AJ, McDermid HE (1995) The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet 9(2):132-140
14. Grosse SD, Wordsworth S, Payne K (2008) Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet Med 10(9):648-654. doi:10.1097/GIM.0b013e3181837217
15. Lu XY, Phung MT, Shaw CA, Pham K, Neil SE, Patel A, Sahoo T, Bacino CA, Stankiewicz P, Kang SH, Lalani S, Chinault AC, Lupski JR, Cheung SW, Beaudet AL (2008) Genomic imbalances in neonates with birth defects: high detection rates by using chromosomal microarray analysis. Pediatrics 122(6):1310-1318
16. Macri JN, Kasturi RV, Krantz DA, Cook EJ (1991) Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age. Obstet Gynecol 77(6):963-965
17. Mansfield ES (1993) Diagnosis of Down syndrome and other aneuploidies using quantitative polymerase chain reaction and small tandem repeat polymorphisms. Hum Mol Genet 2(1):43-50
18. Maya I, Davidov B, Gershovitz L, Zalzstein Y, Taub E, Coppinger J, Shaffer LG, Shohat M (2010) Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting. Prenat Diagn 30(12-13):1131-1137. doi:10.1002/pd.2626
19. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, Scherer SW, Spinner NB, Stavropoulos DJ, Tepperberg JH, Thorland EC, Vermeesch JR, Waggoner DJ, Watson MS, Martin CL, Ledbetter DH (2010) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86(5):749-764
20. MRC working party on the evaluation of chorion villus sampling (1991) Medical Research Council European trial of chorion villus sampling. Lancet 337 (8756):1491-1499
21. Pertl B, Yau SC, Sherlock J, Davies AF, Mathew CG, Adinolfi M (1994) Rapid molecular method for prenatal detection of Down's syndrome. Lancet 343(8907):1197-1198
22. Regier DA, Friedman JM, Marra CA (2010) Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am J Hum Genet 86(5):765-772. doi: 10.1016/j.ajhg.2010.03.009
23. Sahoo T, Cheung SW, Ward P, Darilek S, Patel A, del Gaudio D, Kang SH, Lalani SR, Li J, McAdoo S, Burke A, Shaw CA, Stankiewicz P, Chinault AC, Van den Veyver IB, Roa BB, Beaudet AL, Eng CM (2006) Prenatal diagnosis of chromosomal abnormalities using array-based comparative genomic hybridization. Genet Med 8(11):719-727
24. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30(12):e57
25. Shaffer LG, Bui TH (2007) Molecular cytogenetic and rapid aneuploidy detection methods in prenatal diagnosis. Am J Med Genet 145C(1):87-98
26. Steele MW, Breg WR Jr (1966) Chromosome analysis of human amniotic-fluid cells. Lancet 1(7434):383-385
27. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B (1986) Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1(8493):1287-1293
28. Van den Veyver IB, Patel A, Shaw CA, Pursley AN, Kang SH, Simovich MJ, Ward PA, Darilek S, Johnson A, Neill SE, Bi W, White LD, Eng CM, Lupski JR, Cheung SW, Beaudet AL (2009) Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn 29(1):29-39
29. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA (1988) Maternal serum screening for Down's syndrome in early pregnancy. BMJ (Clin Res ed) 297 (6653):883-887